Concepedia

Simon Buatois

SB

5

Publications

182

Citations

5

H-Index

2017

Active since

Affiliations

Roche (Switzerland)(Current)

Ulsan College

University of Ulsan

Uppsala University

Siriraj Hospital

Simon Buatois is an author at Roche (Switzerland) specializing in medicine, pharmacodynamic modeling, and statistics.

ORCID

Top concepts

Publications per year

2017–2024

5

Publications

5

Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson’s Disease Patients

Simon Buatois, Sylvie Retout, Nicolas Frey et al. · Pharmaceutical Research · 2017 · 44 citations · Full text

, , +8

Comparison of Model Averaging and Model Selection in Dose Finding Trials Analyzed by Nonlinear Mixed Effect Models

Simon Buatois, Sebastian Ueckert, Nicolas Frey et al. · The AAPS Journal · 2018 · 36 citations · Full text

, , +8

Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

Edward Gane, Man‐Fung Yuen, Dong Joon Kim et al. · Hepatology · 2021 · 35 citations · Full text

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria

Phillip Scheinberg, Diego V. Clé, Jin Seok Kim et al. · American Journal of Hematology · 2024 · 34 citations · Full text

Phase 3 randomized <scp>COMMODORE</scp> 2 trial: Crovalimab versus eculizumab in patients with <scp>paroxysmal nocturnal hemoglobinuria</scp> naive to complement inhibition

Alexander Röth, Guangsheng He, Hongyan Tong et al. · American Journal of Hematology · 2024 · 33 citations · Full text

Rows per page

1–5 of 5